Literature DB >> 14516433

Genetic analysis in Leber's hereditary optic neuropathy using the comparative genomic hybridization technique.

May-Yung Yen1, Yann-Jang Chen, Chi-Hung Lin, An-Guor Wang, Yau-Huei Wei.   

Abstract

BACKGROUND: Nuclear genes are suggested to be involved in the pathogenesis of Leber's hereditary optic neuropathy (LHON) but it has not been confirmed. The aim of the present study was to investigate chromosomal abnormalities associated with LHON.
METHODS: In a prospective study, comparative genomic hybridization (CGH) was used to analyse genetic changes in five patients with LHON with an 11778 mitochondrial DNA mutation and three asymptomatic maternal relatives.
RESULTS: There were no significant genetic copy number alterations detected in the five visually affected patients or in the three unaffected maternal relatives as compared to unrelated normal controls.
CONCLUSION: The CGH technique did not detect any chromosomal abnormalities in LHON patients or in unaffected relatives. Nuclear gene involvement, however, cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14516433     DOI: 10.1046/j.1442-9071.2003.00692.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  3 in total

1.  MGB probe assay for rapid detection of mtDNA11778 mutation in the Chinese LHON patients by real-time PCR.

Authors:  Jian-yong Wang; Yang-shun Gu; Jing Wang; Yi Tong; Ying Wang; Jun-bing Shao; Ming Qi
Journal:  J Zhejiang Univ Sci B       Date:  2008-08       Impact factor: 3.066

2.  Candidate Modifier Genes for the Penetrance of Leber's Hereditary Optic Neuropathy.

Authors:  Hui-Chen Cheng; Sheng-Chu Chi; Chiao-Ying Liang; Jenn-Yah Yu; An-Guor Wang
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

3.  High-resolution analysis of DNA copy number alterations in patients with primary open-angle glaucoma.

Authors:  Khaled K Abu-Amero; Ali Hellani; Patrick Bender; George L Spaeth; Jonathan Myers; L Jay Katz; Marlene Moster; Thomas M Bosley
Journal:  Mol Vis       Date:  2009-08-15       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.